Aston Martin Lagonda Global Holdings plc (AMGDF)

Verve Therapeutics Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	123.6	359.6	392.4	583.3	418.9	489.4
Cash & Short-Term Investments	199.5	359.6	392.4	583.3	418.9	489.4
Cash Growth	15.52%	-8.36%	-32.73%	39.25%	-14.41%	353.57%
Accounts Receivable	197.8	125.5	216.2	137	139.5	101.7
Other Receivables	-	56.6	60.3	63.3	56.6	52.8
Receivables	197.8	182.1	276.5	200.9	196.1	154.5
Inventory	353.7	303	272.7	286.2	196.8	207.4
Prepaid Expenses	-	27.6	46.6	46.8	48.8	23.6
Restricted Cash	-	-	-	0.3	-	-
Other Current Assets	11.5	1	3.3	7.9	7.3	14.6
Total Current Assets	762.5	873.3	991.5	1,125	867.9	889.5
Property, Plant & Equipment	440.8	421.3	424.1	444.3	431.5	461
Long-Term Investments	-	50.9	18.2	-	-	-
Goodwill	-	85.4	85.4	85.4	85.4	85.4
Other Intangible Assets	1,692	651.3	643.8	2,311	465.4	467.3
Long-Term Deferred Tax Assets	113.4	126.4	156.3	133.7	156.4	106.5
Long-Term Deferred Charges	-	922.4	848.4	-1,002	833.3	784.1
Other Long-Term Assets	43.2	30.5	5.3	6.3	2.6	1
Total Assets	3,052	3,162	3,173	3,104	2,843	2,795
Accounts Payable	633	108.1	143.2	151.2	114.4	105.6
Accrued Expenses	-	388.8	356.5	346	239.2	200.4
Short-Term Debt	38	38.4	39.7	38.2	19.7	-
Current Portion of Long-Term Debt	-	-	89.4	107.1	114.3	113.5
Current Portion of Leases	9.8	9.4	8.8	7.4	9.7	9.3
Current Income Taxes Payable	2.6	5.7	2.1	6.3	5.5	1.2
Current Unearned Revenue	-	122.9	301	355.8	347.7	272.9
Other Current Liabilities	22.2	30.3	45.4	44.8	54.7	105.4
Total Current Liabilities	705.6	703.6	986.1	1,057	905.2	808.3
Long-Term Debt	1,369	1,387	980.3	1,104	1,075	971.3
Long-Term Leases	84.2	87.2	88.5	92.4	93.7	93.7
Long-Term Unearned Revenue	-	73.4	49.8	42.6	9.8	7.5
Long-Term Deferred Tax Liabilities	-	-	-	0.7	0.8	0.6
Other Long-Term Liabilities	182.9	128.4	96.2	23.1	19	16.8
Total Liabilities	2,367	2,409	2,250	2,381	2,182	1,991
Common Stock	101.1	93.6	82.4	69.9	11.6	11.5
Additional Paid-In Capital	2,193	2,193	2,095	1,697	1,123	1,108
Retained Earnings	-1,836	-1,707	-1,438	-1,234	-662.4	-503.1
Comprehensive Income & Other	214.2	161.2	163.1	170.6	169.2	171.2
Total Common Equity	671.9	740.2	902.3	704	641.8	787.8
Minority Interest	12.8	12.7	20.8	19.5	18.6	16.3
Shareholders' Equity	684.7	752.9	923.1	723.5	660.4	804.1
Total Liabilities & Equity	3,052	3,162	3,173	3,104	2,843	2,795
Total Debt	1,501	1,522	1,207	1,349	1,312	1,188
Net Cash (Debt)	-1,302	-1,163	-814.3	-765.8	-893.4	-698.4
Net Cash Per Share	-1.45	-1.40	-1.09	-1.80	-7.74	-9.05
Filing Date Shares Outstanding	1,011	936.27	823.66	698.76	116.46	114.93
Total Common Shares Outstanding	1,011	936.27	823.66	698.76	116.46	114.93
Working Capital	56.9	169.7	5.4	68.6	-37.3	81.2
Book Value Per Share	0.66	0.79	1.10	1.01	5.51	6.85
Tangible Book Value	-1,020	3.5	173.1	-1,693	91	235.1
Tangible Book Value Per Share	-1.01	0.00	0.21	-2.42	0.78	2.05
Land	-	6.1	6.1	6.1	6.1	6.1
Buildings	-	82	77.2	68.6	65.4	62.6
Machinery	-	1,014	942.3	878.2	786.9	761.2

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.